Talking with your doctor about chemotherapy-induced nausea and vomiting (CINV)

Many people who receive chemotherapy may experience CINV. If you are starting chemotherapy, it is important that you discuss your concerns about CINV with your doctor or nurse. With medication, nausea and vomiting from certain types of chemotherapy may be prevented.

Questions to help you get started

If you are scheduled to receive chemotherapy for the first time, ask your healthcare provider the following:

  • What are the chances that my chemotherapy side effects will include nausea and vomiting?

  • If CINV is going to occur, when should I expect it and how long will it last?

  • Does my background or medical history increase my risk of experiencing CINV?

  • What types of medication will I be given to reduce the risk of CINV, and how will I take them?

  • What nondrug measures can I take to reduce my risk of CINV or to help if I experience CINV?

  • What are some of the effects of nausea and vomiting, and what do I need to look out for?

If you have already experienced CINV, do the following:

  • First, tell your healthcare provider about your prior experiences with CINV and the measures you took to relieve or prevent CINV (medications as well as lifestyle changes)

Then, ask the following questions:

  • Why do I feel sick to my stomach after I have received chemotherapy?

  • Are there different medications that I can take to reduce my risk of CINV?

  • Can you recommend other strategies that may help reduce the likelihood of experiencing CINV?

Indication in Adults

  • ALOXI® injection 0.25 mg/5 mL is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.

Indication in Pediatrics

  • ALOXI injection 20 mcg/kg (max 1.5 mg) is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.

Important Safety Information

  • ALOXI can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and chest pain

  • The most common side effects of ALOXI in adults are headache and constipation

  • Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed

For more information about ALOXI, talk to your doctor or see full Prescribing Information.

ALOXI is available by prescription only.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

This site is intended for residents of the United States only. Any products discussed herein may have different product labeling in different countries.

This website contains information relating to various medical conditions and treatment. Such information is provided for educational purposes only and is not meant to be a substitute for the advice of a physician or other healthcare professionals. You should not use this information for diagnosing a health problem or disease. In order for you to make intelligent healthcare decisions, you should always consult with a physician or other healthcare provider for you, or your loved ones', personal medical needs. All quotes included in this website represent the individual experience of some doctors, some patients, and their caregivers. Individual responses to treatment may vary. Actual identities have been changed to protect individual privacy.

To report SUSPECTED ADVERSE REACTIONS, contact EISAI at 1-888-422-4743 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

ALOXI® is a registered trademark of Helsinn Healthcare SA, Switzerland, used under license.
Distributed by Eisai Inc. under license of Helsinn Healthcare SA, Switzerland. Marketed by Eisai Inc. and Helsinn Therapeutics (U.S.), Inc.
© 2016 Eisai Inc. All rights reserved. ALOX-US0149 07/16

Important Safety Information Expand

Indication in Adults

  • ALOXI® injection 0.25 mg/5 mL is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.

Indication in Pediatrics

  • ALOXI injection 20 mcg/kg (max 1.5 mg) is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.

Important Safety Information

  • ALOXI can cause allergic reactions that can be serious. Tell your doctor or nurse right away if you have any of these following symptoms of a serious allergic reaction: hives, swelling of the face, trouble breathing and chest pain

  • The most common side effects of ALOXI in adults are headache and constipation

  • Tell your doctor or nurse if you are taking other medications or if you are pregnant or breastfeeding or plan to become pregnant or breastfeed

For more information about ALOXI, talk to your doctor or see full Prescribing Information.

ALOXI is available by prescription only.

You are now leaving ALOXI.com

Eisai Inc. does not review the information contained on the following website for content, accuracy, or completeness. Use of and access to the information is subject to the terms, limitations, and conditions set by the website producer. Eisai Inc. makes no claims about the accuracy or any other aspect of the information contained on this website, nor does Eisai Inc. endorse this website.

CANCEL CONTINUE

Healthcare professionals

This information is intended for US healthcare professionals. Click the "CONTINUE" button below to verify that you are a US healthcare professional, or the "CANCEL" button to return to the previous page.

CANCEL CONTINUE